Literature DB >> 3505922

Euthanasia of rabbits by intravenous administration of ketamine.

P J Baneux1, D Garner, H B McIntyre, H J Holshuh.   

Abstract

Six New Zealand White rabbits (5 females and 1 male) were anesthetized with a combination of xylazine (4.3 mg/kg of body weight) and ketamine (29.1 mg/kg) administered IM. The rabbits were then attached to instruments that continuously monitored blood pressure and electrocardiographic and electroencephalographic values. Each rabbit was then administered a lethal dose of ketamine (600 mg, IV). Within 90 seconds after injection of the ketamine, brain death developed and the heart rate and blood pressure decreased greatly. Circulatory activity persisted for a maximum of 240 seconds. This method of euthanasia did not result in histopathologic changes in tissue specimens evaluated. Although death occurred rapidly, extensive muscle contractions made euthanasia of rabbits with ketamine aesthetically unacceptable. Therefore, this method would not be a suitable means of euthanasia for routine use in rabbits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3505922

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  11β-hydroxysteroid dehydrogenases as targets in the treatment of steroid-associated femoral head necrosis using antler extract.

Authors:  Ribusurong Pu; Hao Peng
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

2.  MRI tracing of ultrasmall superparamagnetic iron oxide nanoparticle‑labeled endothelial progenitor cells for repairing atherosclerotic vessels in rabbits.

Authors:  Hongxia Wei; Tingting Tan; Li Cheng; Jiapeng Liu; Hongyan Song; Lei Li; Kui Zhang
Journal:  Mol Med Rep       Date:  2020-08-13       Impact factor: 2.952

3.  Histomorphometric comparison of the corpus cavernosum of rats submitted to euthanasia with ketamine and xylazine or isoflurane.

Authors:  Isabella Mendes Procópio; Marco Aurélio Pereira-Sampaio; Waldemar Silva Costa; Francisco José Barcellos Sampaio; Diogo Benchimol de Souza
Journal:  Acta Cir Bras       Date:  2021-12-08       Impact factor: 1.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.